Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Remarks:
Type of genotoxicity: gene mutation
Adequacy of study:
other information

Data source

Reference
Reference Type:
other: Body responsible for the test
Title:
Unnamed

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
other: Annex V (Ames)
GLP compliance:
yes
Type of assay:
bacterial reverse mutation assay

Method

Species / strain
Species / strain / cell type:
bacteria, other: Salmonella typhimurium (TA1535, TA1537, TA100 and TA98) and Escherichia coli WP2uvrA
Metabolic activation system:
Aroclor induced rat liver S9
Test concentrations with justification for top dose:
Concentration range in the main test (with metabolic activation): 100 ... 5000 µg/plate
Concentration range in the main test (without metabolic activation): 100 ... 5000 µg/plate
Vehicle / solvent:
Solvent: Dimethylsulfoxide
Details on test system and experimental conditions:
Concentration of the test substance resulting in precipitation: 5000 µg/plate

Results and discussion

Test resultsopen allclose all
Species / strain:
other: as specified above
Metabolic activation:
with
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
( 5000 µg/plate)
Species / strain:
other: as specified above
Metabolic activation:
without
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
( 5000 µg/plate)
Additional information on results:
Observations:
Without S9-mix:

In tester strain TA1537, STI571 D6 induced up to 5.8-fold,
dose related, increase in the number of revertant colonies
compared to the solvent control in the first experiment and
up to 2.7-fold, not dose related, increase in the second
experiment.


In the other four tester strains (TA1535, TA98, TA100 and
WP2uvrA), STI571 D6 did not induce a dose-related, two-fold,
increase in the number of revertant colonies in two
independently repeated experiments.


With S9-mix:

In tester strain TA1537, STI571 D6 induced up to 6.5-fold,
dose related, increase in the number of revertant colonies
compared to the solvent control in the first experiment and
up to 3.7-fold, not dose related, increase in the second
experiment. In tester strain TA98, STI571 D6 induced up to
1.4- and 3.9-fold, dose related, increases in the number of
revertant colonies compared to the solvent control in the
first and second experiment, respectively. In tester strain
TA100, STI571 D6 induced up to 5.1- and 6.7-fold, dose
related, increases in the number of revertant colonies
compared to the solvent control in the first and second
experiment, respectively.


In the other two tester strains (TA1535 and WP2uvrA), STI571
D6 did not induce a dose-related, two-fold, increase in the
number of revertant colonies in two independently repeated
experiments.


Based on the results of this study it is concluded that
STI571 D6 is mutagenic in the Salmonella typhimurium reverse
mutation assay and STI571 D6 is not mutagenic in the
Escherichia coli reverse mutation assay.
Remarks on result:
other: other: preliminary test
Remarks:
Migrated from field 'Test system'.

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information):
positive with metabolic activation
positive without metabolic activation